TORLEY HELEN (PRESIDENT AND CEO) sold 0.2% of their position (1.92K shares) of HALOZYME THERAPEUTICS, INC. on the open market
Open‑market sale worth $153.4K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 2 sales
Filed: 7/9/2026ACC: 0001159036-26-000100
DirectorOfficer· PRESIDENT AND CEO
Since Mar 2026
-1.92K
Net shares
Net seller
$153.4K
Total sold
2
Open market trades
0B · 2S
4
Total transactions
1.92K acquired · 3.85K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
+1.92K
Price / share
$12.07
Trade value
$23.21K
% of position
0.3%
7/8/2026
767.78K→769.70K
Common Stock
Direct
Shares
−888.00
Price / share
$79.28
Trade value
$70.40K
% of position
0.1%
7/8/2026
769.70K→768.82K
Common Stock
Direct
Shares
−1.03K
Price / share
$80.19
Trade value
$82.99K
% of position
0.1%
7/8/2026
768.82K→767.78K
Total
Net shares
+0.00
Net value
-$130.18K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 7/8/2026 | M · Option Exercise | +1.92K | $12.07 | $23.21K | 0.3% | 767.78K | 769.70K |
| Common Stock Direct | 7/8/2026 | S · Sale | −888.00 | $79.28 | $70.40K | 0.1% | 769.70K | 768.82K |
| Common Stock Direct | 7/8/2026 | S · Sale | −1.03K | $80.19 | $82.99K | 0.1% | 768.82K | 767.78K |
| Total | +0.00 | -$130.18K | ||||||
Derivative Transactions1
Option to Purchase Common Stock
Direct
Converts to
Common Stock
1.92K shares
Shares
−1.92K
Strike price
12.07
Held after
0.00
Exercisable
—
7/8/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Option to Purchase Common Stock Direct | Common Stock1.92K shares | 7/8/2026 | M · Option Exercise | −1.92K | 12.07 | — | 0.00 |